JCM
PFE icon

Jacobi Capital Management’s Pfizer PFE Stock Holding History

Jacobi Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81M Buy
135,676
+3,479
+3% +$92.6K 0.21% 86
2025
Q4 		$3.29M Sell
132,197
-3,912
-3% -$98.7K 0.19% 98
2025
Q3 		$3.47M Buy
136,109
+2,237
+2% +$55.2K 0.21% 84
2025
Q2 		$3.25M Buy
133,872
+4,671
+4% +$109K 0.22% 88
2025
Q1 		$3.27M Buy
129,201
+4,285
+3% +$112K 0.24% 76
2024
Q4 		$3.31M Buy
124,916
+914
+0.7% +$24.8K 0.25% 81
2024
Q3 		$3.59M Buy
124,002
+2,015
+2% +$58.8K 0.27% 70
2024
Q2 		$3.41M Buy
121,987
+853
+0.7% +$23.5K 0.3% 62
2024
Q1 		$3.36M Buy
121,134
+324
+0.3% +$8.99K 0.31% 53
2023
Q4 		$3.48M Buy
120,810
+3,904
+3% +$118K 0.36% 49
2023
Q3 		$3.88M Buy
116,906
+4,406
+4% +$156K 0.44% 40
2023
Q2 		$4.13M Buy
112,500
+937
+0.8% +$36.5K 0.46% 40
2023
Q1 		$4.55M Sell
111,563
-3,847
-3% -$166K 0.54% 34
2022
Q4 		$5.91M Buy
115,410
+5,630
+5% +$270K 0.74% 24
2022
Q3 		$4.8M Buy
109,780
+3,901
+4% +$190K 0.66% 25
2022
Q2 		$5.55M Sell
105,879
-1,416
-1% -$72.2K 0.74% 21
2022
Q1 		$5.55M Buy
107,295
+1,673
+2% +$86.8K 0.66% 22
2021
Q4 		$6.24M Buy
105,622
+1,556
+1% +$77.1K 0.74% 20
2021
Q3 		$4.48M Buy
104,066
+1,755
+2% +$77.7K 0.57% 25
2021
Q2 		$4.01M Buy
102,311
+704
+0.7% +$27.4K 0.53% 28
2021
Q1 		$3.68M Buy
101,607
+4,023
+4% +$143K 0.54% 26
2020
Q4 		$3.61M Sell
97,584
-15,414
-14% -$565K 0.57% 26
2020
Q3 		$3.98M Buy
112,998
+20,581
+22% +$722K 0.7% 25
2020
Q2 		$3.73M Sell
92,417
-20,125
-18% -$684K 0.7% 25
2020
Q1 		$3.58M Buy
112,542
+3,124
+3% +$106K 0.77% 25
2019
Q4 		$4.08M Buy
109,418
+4,524
+4% +$161K 0.75% 24
2019
Q3 		$3.59M Sell
104,894
-224
-0.2% -$8.14K 0.71% 25
2019
Q2 		$4.32M Buy
105,118
+30,779
+41% +$1.22M 0.88% 19
2019
Q1 		$3M Buy
74,339
+6,529
+10% +$261K 0.76% 23
2018
Q4 		$2.81M Buy
67,810
+15,727
+30% +$653K 0.77% 24
2018
Q3 		$2.18M Buy
52,083
+1,375
+3% +$52.9K 0.58% 25
2018
Q2 		$1.75M Buy
50,708
+4,039
+9% +$138K 0.5% 30
2018
Q1 		$1.55M Buy
46,669
+8,429
+22% +$290K 0.47% 33
2017
Q4 		$1.32M Buy
38,240
+123
+0.3% +$4.19K 0.43% 42
2017
Q3 		$1.31M Buy
38,117
+850
+2% +$27.3K 0.44% 39
2017
Q2 		$1.18M Sell
37,267
-1,653
-4% -$52.1K 0.46% 36
2017
Q1 		$1.26M Buy
38,920
+977
+3% +$30.8K 0.65% 32
2016
Q4 		$1.18M Sell
37,943
-2,623
-6% -$80.1K 0.72% 31
2016
Q3 		$1.3M Buy
40,566
+143
+0.4% +$4.78K 0.61% 31
2016
Q2 		$1.38M Buy
+40,423
New +$1.29M 0.69% 26

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jacobi Capital Management's PFE Position: Q1 2026 in Review

Jacobi Capital Management increased its Pfizer (PFE) stake by 2.6% in Q1 2026, buying an estimated $92.6K and bringing the position to 135,676 shares worth $3.81M. The position accounts for 0.21% of the portfolio, ranked #86.

Jacobi Capital Management first reported a position in PFE in Q2 2016 and has held it in 40 quarters since. The position peaked at $6.24M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Jacobi Capital Management held 135,676 shares of Pfizer worth $3.81M as of Q1 2026.
  • Jacobi Capital Management bought 3,479 Pfizer shares in Q1 2026, an estimated $92.6K.
  • Pfizer made up 0.21% of Jacobi Capital Management's portfolio in Q1 2026, its #86 holding.
  • Jacobi Capital Management first reported a position in Pfizer in Q2 2016 and has held it in 40 quarters since.
  • Jacobi Capital Management's Pfizer position peaked at $6.24M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.